Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Gregory

Concepts (182)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
fms-Like Tyrosine Kinase 3
4
2022
43
1.270
Why?
Proto-Oncogene Proteins c-myc
7
2012
115
0.960
Why?
Leukemia, Myeloid, Acute
3
2022
534
0.860
Why?
Glutamine
2
2019
91
0.770
Why?
Benzothiazoles
2
2017
32
0.720
Why?
Phenylurea Compounds
2
2017
82
0.690
Why?
Drug Resistance, Neoplasm
4
2022
636
0.650
Why?
Oxidation-Reduction
2
2019
923
0.620
Why?
Benzeneacetamides
1
2017
7
0.590
Why?
Glutaminase
1
2017
10
0.590
Why?
Thiadiazoles
1
2017
21
0.580
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2014
95
0.560
Why?
Leukemia
1
2019
209
0.550
Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
63
0.540
Why?
Glucosephosphate Dehydrogenase
1
2016
37
0.540
Why?
Gene Expression Regulation, Leukemic
1
2016
49
0.540
Why?
Fusion Proteins, bcr-abl
3
2014
61
0.490
Why?
Antineoplastic Agents
4
2023
1879
0.490
Why?
Energy Metabolism
1
2019
731
0.450
Why?
Xenograft Model Antitumor Assays
4
2019
698
0.400
Why?
Cell Line, Tumor
9
2022
2710
0.390
Why?
Protein Kinase Inhibitors
6
2022
785
0.360
Why?
Philadelphia Chromosome
1
2010
15
0.360
Why?
NFATC Transcription Factors
1
2010
78
0.340
Why?
Wnt Proteins
1
2010
134
0.330
Why?
Glycogen Synthase Kinase 3
2
2012
77
0.320
Why?
Cell Proliferation
4
2019
2186
0.320
Why?
Apoptosis
10
2022
2362
0.310
Why?
Tumor Suppressor Protein p14ARF
2
2005
6
0.310
Why?
Mice, Inbred NOD
3
2017
555
0.270
Why?
Calcium
2
2013
1104
0.250
Why?
Cell Survival
3
2019
1020
0.250
Why?
RNA, Small Interfering
4
2016
535
0.240
Why?
Mice
12
2019
14860
0.230
Why?
Ubiquitins
2
2000
31
0.220
Why?
Cysteine Endopeptidases
2
2000
60
0.220
Why?
Cell Nucleus
2
2003
554
0.220
Why?
Multienzyme Complexes
2
2000
64
0.220
Why?
Cyclosporine
3
2014
161
0.220
Why?
Mice, Transgenic
2
2019
1947
0.210
Why?
Burkitt Lymphoma
2
2000
52
0.210
Why?
Peptide Hydrolases
1
2003
104
0.210
Why?
Animals
15
2019
31694
0.210
Why?
Genes, myc
2
2012
46
0.210
Why?
Epididymis
1
2000
9
0.180
Why?
Hormones
1
2000
132
0.170
Why?
Cell Division
2
2004
758
0.170
Why?
Head and Neck Neoplasms
1
2023
427
0.160
Why?
Phosphorylation
6
2022
1569
0.150
Why?
Hydrazines
1
2016
28
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2014
1355
0.140
Why?
Reactive Oxygen Species
1
2019
531
0.140
Why?
Transfection
4
2004
866
0.130
Why?
Signal Transduction
5
2016
4509
0.130
Why?
Molecular Targeted Therapy
1
2019
347
0.130
Why?
Glutamic Acid
1
2017
211
0.130
Why?
Oligomycins
1
2014
8
0.120
Why?
Mitochondrial Proton-Translocating ATPases
1
2014
17
0.120
Why?
RNA Interference
2
2014
433
0.120
Why?
Imatinib Mesylate
2
2014
63
0.120
Why?
Threonine
2
2012
40
0.120
Why?
Dasatinib
2
2014
46
0.120
Why?
Tumor Cells, Cultured
2
2010
849
0.120
Why?
Calcineurin Inhibitors
1
2014
58
0.110
Why?
Thiazoles
2
2014
110
0.110
Why?
Drug Therapy, Combination
1
2016
951
0.110
Why?
Flow Cytometry
3
2014
1083
0.110
Why?
Proto-Oncogene Proteins c-bcl-2
2
2012
213
0.110
Why?
Survival Analysis
1
2016
1211
0.110
Why?
Humans
17
2023
114623
0.110
Why?
Gene Expression Regulation
2
2004
2319
0.100
Why?
Cyclin-Dependent Kinase Inhibitor p16
3
2012
57
0.100
Why?
Benzimidazoles
1
2013
138
0.100
Why?
Disease Models, Animal
2
2019
3531
0.100
Why?
Cell Line
4
2005
2635
0.100
Why?
Pyrimidines
2
2014
376
0.090
Why?
Blotting, Western
2
2012
1147
0.090
Why?
Hematologic Neoplasms
1
2013
137
0.090
Why?
Tumor Suppressor Protein p53
2
2005
445
0.090
Why?
Tumor Microenvironment
2
2023
430
0.090
Why?
Amino Acid Substitution
3
2012
262
0.090
Why?
Cell Transformation, Neoplastic
3
2012
308
0.090
Why?
COS Cells
2
2000
175
0.090
Why?
Proteasome Endopeptidase Complex
2
2000
133
0.080
Why?
Benzamides
1
2010
169
0.080
Why?
Neoplasm Proteins
2
2004
384
0.080
Why?
Mitosis
2
2000
164
0.080
Why?
Female
6
2017
59466
0.080
Why?
Mice, Inbred C57BL
3
2014
4689
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
923
0.080
Why?
Piperazines
1
2010
309
0.070
Why?
Colorectal Neoplasms
1
2013
615
0.070
Why?
Immunosuppressive Agents
1
2010
646
0.070
Why?
Binding Sites
2
2004
1168
0.060
Why?
Enzyme Inhibitors
2
2023
750
0.060
Why?
Ubiquitin
1
2003
57
0.050
Why?
Transcriptional Activation
1
2005
337
0.050
Why?
RNA, Messenger
1
2010
2552
0.050
Why?
Mitogen-Activated Protein Kinases
1
2004
278
0.050
Why?
Cytokines
1
2010
1840
0.050
Why?
Mutation
3
2022
3344
0.050
Why?
Everolimus
1
2022
61
0.050
Why?
Gene Expression Regulation, Neoplastic
2
2005
1141
0.050
Why?
Oxidative Phosphorylation
1
2022
155
0.050
Why?
Protein Binding
2
2004
1889
0.050
Why?
Growth Inhibitors
1
2000
43
0.050
Why?
Adrenal Glands
1
2000
66
0.040
Why?
Amino Acid Sequence
2
2004
1982
0.040
Why?
Cysteine Proteinase Inhibitors
1
2000
45
0.040
Why?
DNA, Complementary
1
2000
256
0.040
Why?
3T3 Cells
1
2000
140
0.040
Why?
Organ Specificity
1
2000
268
0.040
Why?
Mammary Glands, Animal
1
2000
117
0.040
Why?
TOR Serine-Threonine Kinases
1
2022
358
0.040
Why?
Pituitary Gland
1
2000
148
0.040
Why?
Sequence Deletion
1
2000
167
0.040
Why?
Molecular Sequence Data
2
2004
2785
0.040
Why?
Prostate
1
2000
156
0.040
Why?
Middle Aged
2
2016
26719
0.040
Why?
Tubulin
1
2000
123
0.040
Why?
Uterus
1
2000
192
0.040
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2012
22
0.040
Why?
Ovary
1
2000
191
0.040
Why?
CHO Cells
2
2012
138
0.040
Why?
Cricetinae
2
2012
253
0.040
Why?
Protein Processing, Post-Translational
1
2000
399
0.040
Why?
Recombinant Fusion Proteins
1
2000
616
0.040
Why?
Nerve Tissue Proteins
1
2000
529
0.030
Why?
Protein Structure, Tertiary
2
2012
796
0.030
Why?
Rats
2
2004
4958
0.030
Why?
Fibroblasts
1
2000
837
0.030
Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
Why?
Ketone Oxidoreductases
1
2014
7
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
55
0.030
Why?
Precipitin Tests
2
2004
88
0.030
Why?
Superoxides
1
2014
214
0.030
Why?
Drug Synergism
1
2014
316
0.030
Why?
Transcription, Genetic
2
2012
1313
0.030
Why?
Early Growth Response Protein 1
1
2012
24
0.030
Why?
S-Phase Kinase-Associated Proteins
1
2012
18
0.030
Why?
MAP Kinase Kinase Kinases
1
2013
68
0.030
Why?
Mitochondrial Proteins
1
2014
219
0.030
Why?
Binding, Competitive
1
2012
193
0.030
Why?
Ubiquitination
1
2012
86
0.030
Why?
Vinblastine
1
2012
63
0.030
Why?
Gene Knockout Techniques
1
2012
98
0.030
Why?
Cytarabine
1
2012
51
0.030
Why?
Peptide Mapping
2
2004
60
0.030
Why?
ras Proteins
1
2013
138
0.030
Why?
Etoposide
1
2012
148
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2013
228
0.030
Why?
Protein Stability
1
2012
157
0.020
Why?
Mutagenesis, Site-Directed
1
2012
345
0.020
Why?
Wnt Signaling Pathway
1
2013
146
0.020
Why?
Protein-Tyrosine Kinases
1
2014
395
0.020
Why?
Calcium Signaling
1
2013
213
0.020
Why?
HeLa Cells
1
2012
562
0.020
Why?
Cisplatin
1
2012
262
0.020
Why?
Proto-Oncogene Proteins
1
2013
608
0.020
Why?
Mitochondria
1
2014
747
0.020
Why?
Brain
1
2000
2371
0.020
Why?
Mice, Knockout
1
2014
2565
0.020
Why?
Genomics
1
2013
635
0.020
Why?
Cells, Cultured
1
2012
3881
0.020
Why?
Okadaic Acid
1
2004
11
0.010
Why?
Tetradecanoylphorbol Acetate
1
2004
153
0.010
Why?
Carcinogens
1
2004
103
0.010
Why?
Dogs
1
2004
334
0.010
Why?
Paclitaxel
1
2004
190
0.010
Why?
Antineoplastic Agents, Phytogenic
1
2004
181
0.010
Why?
Gene Deletion
1
2004
356
0.010
Why?
Protein Kinase C
1
2004
273
0.010
Why?
MAP Kinase Signaling System
1
2004
276
0.010
Why?
Enzyme Activation
1
2004
785
0.010
Why?
Male
2
2014
55554
0.010
Why?
Cell Cycle
1
2004
542
0.010
Why?
Treatment Outcome
1
2014
9084
0.010
Why?
Dose-Response Relationship, Drug
1
2004
1842
0.010
Why?
Phosphoproteins
1
2000
298
0.010
Why?
Microtubules
1
2000
237
0.010
Why?
Time Factors
1
2004
6112
0.010
Why?
Adult
1
2014
30528
0.010
Why?
Gregory's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)